HIPRAVIAR AP

HIPRAVIAR AP

 Inactivated vaccine against Pigeon paramyxovirosis, in 
suspension for injection

 QUALITATIVE AND QUANTITATIVE COMPOSITION OF THE ACTIVE SUBSTANCE:

 One dose (0,2 ml) contains:
 Inactivated Paramixovirus-1, strain AP 1282 ≥ 1/16 HAI*
 *HAI: Antibody titre obtained by means of hemagglutination inhibition.

 INDICATIONS:

 For active immunization of pigeon to prevent Paramyxovirus infections.
 CONTRA-INDICATIONS:
 None.

 ADVERSE REACTIONS:

 If inoculation by subcutaneous route is not correct and it is carried out by intradermic 
route, it may produce a regional oedema of favourable evolution.
 If you notice any serious effects not mentioned in this leaet, please inform your 
veterinarian.

 TARGET SPECIES: 

Pigeons (males and females).

 POSOLOGY FOR EACH TARGET SPECIES, METHOD AND ROUTES OF 
ADMINISTRATION:

 Pigeons: 0.2 ml/bird.
 Administer by subcutaneous route into the mid back region of the neck.
 Recommended vaccination programme:
 First vaccination: administer one dose (0.2 ml) of HIPRAVIAR AP at 30-35 days of 
age.
 Revaccination: perform at least an annual booster vaccination with 1 dose of the 
vaccine (0.2 ml).

 ADVICE ON CORRECT ADMINISTRATION:

 As it is a vaccine stored in multi-dose bottles, it is preferable to use all the vaccine 
once the bottle is opened.
 Shake before use.
 Use sterile material for its administration.
 Administer the vaccine at a temperature between +15 °C and +25 °C.

 WITHDRAWAL PERIOD:

 Zero days.

 SPECIAL PRECAUTIONS FOR STORAGE:

 Keep out of the sight and reach of children.
 Store and transport refrigerated (2 ºC – 8 ºC). Do not freeze. Protect from light.
 Shelf life after rst opening the container: use immediately.
 Do not use after the expiry date (EXP) stated on the carton and the label.

 SPECIAL WARNINGS:

 Special warnings for each target species 
Vaccinate only healthy animals.
 Use during pregnancy, lactation or lay
 Can be used during the laying period. 
Interactions with other vaccines and medicinal products when administered in 
combination with the product 
No information is available on the safety and ef cacy of this vaccine when used with 
any other veterinary medicinal product. A decision to use this vaccine before or after 
any other veterinary medicinal product therefore needs to be made on a case by 
case basis.
 Overdose 
No alterations have been described when a double dose is administered.
 Incompatibilities
 In the absence of compatibility studies, this veterinary medicinal product must not 
be mixed with other veterinary medicinal products.

 SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED MEDICINAL PRODUCT 
OR WASTE MATERIALS DERIVED FROM THE USE OF SUCH PRODUCTS:

 Any unused veterinary medicinal product or waste materials derived from such 
veterinary medicinal products should be disposed of in accordance with local 
requirements.

 OTHER INFORMATION:

 Pack sizes:
 Box with one vial of 50 doses (10 ml).
 Box with one vial of 100 doses (20 ml).
 Not all pack sizes may be marketed